Hong Yu - Tibet Pharmaceuticals Chairman and CEO
Chairman
Mr. Hong Yu is Chairman of the Board, Chief Executive Officer of Shangri La Tibetan Pharmaceuticals Inc. He was appointed as Chief Executive Officer of the Company on June 6, 2011. Mr. Yu is the founder of YSTP, and has served as its Chairman of the Board and General Manager from 2000 until mid2009 since 2011.
| Age | 64 |
| Tenure | 13 years |
| Professional Marks | MBA |
| Phone | 852 9798 5569 |
| Web | http://www.tibetpharmaceuticals.com |
Tibet Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.1744 % which means that it generated a profit of $0.1744 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3215 %, meaning that it created $0.3215 on every $100 dollars invested by stockholders. Tibet Pharmaceuticals' management efficiency ratios could be used to measure how well Tibet Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Tibet Pharmaceuticals currently holds 4.71 M in liabilities. Tibet Pharmaceuticals has a current ratio of 14.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Tibet Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Sankar DIC | Electrovaya Common Shares | 73 | |
| Frank Stepan | Stepan Company | 60 | |
| Douglas Baker | Ecolab Inc | 62 | |
| PE Esq | NioCorp Developments Ltd | 65 | |
| Seifollah Ghasemi | Air Products and | 80 | |
Management Performance
| Return On Equity | 0.32 | |||
| Return On Asset | 0.17 |
Tibet Pharmaceuticals Leadership Team
Elected by the shareholders, the Tibet Pharmaceuticals' board of directors comprises two types of representatives: Tibet Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tibet. The board's role is to monitor Tibet Pharmaceuticals' management team and ensure that shareholders' interests are well served. Tibet Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tibet Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hong Yu, Chairman and CEO | ||
| Sabrina Ren, CFO and Principal Accounting Officer |
Tibet Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tibet Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.32 | |||
| Return On Asset | 0.17 | |||
| Profit Margin | 0.32 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | (25.96 M) | |||
| Shares Outstanding | 14.85 M | |||
| Revenue | 32.36 M | |||
| Gross Profit | 16.18 M | |||
| EBITDA | 11.53 M | |||
| Net Income | 13.14 M |
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Tibet Stock
If you are still planning to invest in Tibet Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tibet Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |